
Bristol Myers Squibb
Bristol Myers Squibb (BMS) is a multinational pharmaceutical company headquartered in New York City, renowned for its commitment to discovering, developing, and delivering innovative medicines to patients with serious diseases. With a strong emphasis on oncology, immunology, and cardiovascular health, BMS has made significant contributions to the treatment landscape, including breakthroughs in cancer therapies. The company has a robust pipeline of drugs and is dedicated to addressing unmet medical needs through its research and development efforts.
Not in the pool (under ¢1).
Recent news mentions
Bristol Myers Squibb announced it will charge the same price for its schizophrenia drug in the UK as in the US.
Trump und Pfizer mit Abkommen: Günstigere Medikamente im DirektverkaufBristol Myers Squibb is included in the list of American companies announcing major investments in the U.S.
Sanofi promet d’investir 20 milliards de dollars aux Etats-Unis










